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Dwhere the complex anatomy of the sinuses, sinotubular
junction, and coronary ostia make TEVAR with debranch-
ing procedures or branched endografts unfeasible with cur-
rent technology. Their work suggests that in identifying an
endovascular solution to the ascending aorta, a valved
conduit addressing the coronary arteries may need to be
considered as an option.
Study Limitations
Limitations of this study include its retrospective nature
over a long study period. Small differences in operative
technique and perioperative care may have affected out-
comes, although this was not borne out after statistical anal-
ysis based on era of operation. Another limitation included
the lack of complete follow-up with regard to secondary
outcome of reoperation. However, the robust sample size
and long interval of the studymay havemitigated the effects
of this limitation.
CONCLUSIONS
We have presented one of the largest series of open repair
of aortic arch pathology reported in the literature. Our data
suggest that this once dreaded clinical scenario can be ad-
dressed with low rates of morbidity and need for reoperation
in the treated segments. As the therapy of aortic disease
evolves into a more endovascular-based approach, certain
subgroups of patients, such as those with advanced age or
impaired renal function, emerge as ideal candidates for
this application of newer technology.
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DrAlberto Pochettino (Philadelphia, Pa). An outstanding pre-
sentation from master surgeons. It is particularly impressive to me
that you have a 100% follow-up. I am somewhat envious of that. I
found as I reviewed the article that you provided to me that your
use of RCP and selective antegrade perfusion was sensible in my
mind and very safe, which led to the outstanding results. I have
a couple of comments.
The first one relates to using the data that you have from this
series as a benchmark against which newer techniques can be
measured. The majority of your reconstruction involved aortic
root reconstruction in what we would call arch hemi or arch total
arches. That group, even with today’s technology, is not amenable,
I don’t think, to hybrid reconstruction. So I think it would make
sense to look at the isolated arches or isolated arches plus descend-
ing reconstruction that you had and use that group, which accounts
for approximately 13% of your patients, as a benchmark against
which the arch hybrid should be compared. Do you have data on
that group?
Dr Patel.We have not separated the analysis out specifically on
that basis, but we appreciate your comments, understanding the
current limitations of endograft technology. However, we do
know that endograft technology is progressing to the ascending
aorta and may soon include ascending and root procedures as
well, and we believe that these data should be compared with
contemporary open surgical procedures, such as that described
here. But we fully understand and appreciate your comments.
Dr Pochettino.My next comment is about aortic dissection. As
you know, I have come to use what has been described as a frozen
elephant trunk in the treatment of acute type A dissection. You
have a large series of patients with type A dissection, and it would
be useful again as a comparison against which we should look atgery c June 2011
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Dnewer technology at the patients undergoing the DeBakey 1 proce-
dure and how they fare both in terms of freedom from reoperation
and survival. Do you have data on the DeBakey 1 cohort?
Dr Patel. We did not stratify the analysis based on extent of
dissection. Just having been involved in a few of these procedures,
I can suggest to you that a majority of these patients truly had
dissections that extended throughout the aorta, but unfortunately
I do not have that separate analysis as you have requested.
Dr Pochettino. One last question. I noticed from your article
that you have changed your total arch reconstruction from an is-
land to individual segments, to either all 3 of the vessels or at least
2. Have you noticed a decrease in the stroke rate as you changed
your technique?
Dr Patel. That is a great question. Unfortunately, I did not
separate this out into the island versus the individual bypass graft
technique. We will tell you, as probably other surgeons have de-
scribed, some of the bleeding risks may be less with the individual
bypass technique, and we evolved toward that. My senior partner,
Mike Deeb, evolved toward that when I was a resident in 2001, and
since then we have virtually exclusively used the multibranch
grafts that are available to us.
Dr Pochettino. Outstanding series.
Dr John Ikonomidis (Charleston, SC). Himanshu, congratula-
tions on a beautifully presented study of a large population of aor-
tic arch reconstructions. I have a 2-part question for you. I wonder
if it is really appropriate when one considers stroke rates to group
hemi-arch replacements with total arch replacements, because I
think technically they are 2 different operations. An aortic arch re-
construction involves more manipulation of the great vessels, and
one would expect intuitively that it would be associated with
a higher stroke rate, and therefore including hemi-arches in the
analysis would somewhat buffer that effect. My first question is,
did you separate out hemi-arches from full arches, and what
were the relative stroke rates in those? Related to that, did you in-
clude requirement for total arch replacement in your multivariable
analysis to see if that was an independent predictor of stroke?
Dr Patel.When we analyzed the incidence of stroke, we did in-
clude the extent of resection in that analysis, and as a surrogate,
extension into the descending aorta was identified as an indepen-
dent risk factor for stroke. However, whether we used 1, 2, or 3 by-
passes really did not separate out on univariate or multivariate
analysis as a risk factor for stroke.
I will tell you that in our series, the neuroprotection strategy,
whether it was just isolated RCP or a combination of RCP and
ACP, really did not make a difference whether we saw postopera-
tive stroke or not, and I suspect that it is partly because it is
drowned in the numbers, because the bias obviously is that when
we extended to a total arch repair, we would typically use ACP.
If you look at the cerebral ischemic times that were calculated
out for each patient, the cerebral ischemic time for the entire co-
hort was approximately 15 or 16 minutes, whereas the total lowerThe Journal of Thoracic and Carbody circulatory arrest time was approximately 30 to 35 minutes.
So a significant proportion of patients did have an antegrade cere-
bral approach, and perhaps that may have mitigated the effects of
extended arch reconstruction and its effects on stroke as well.
Dr Ali Khoynezhad (Omaha, Neb). Himanshu, that was an ex-
cellent presentation with great results. A question about a subset
(the patients with type A aortic dissection): Not surprisingly,
they had a higher early mortality, reoperation, and probably
a higher stroke rate. Did you look into different cannulation sites,
such as femoral or axillary cannulation for HCA, and did you find
any difference in outcome of those patients? Also, was there any
difference in outcomes by using transcranial Doppler? I adopted
it early on, and this was before, especially since Dr Safi’s group
showed improvement of outcomes by utility intraoperative modi-
fication of the cannulation site when patients went on or came off
pump to reduce cerebral malperfusion.
Dr Patel.We typically do not use other adjunctivemaneuvers to
determine whether there are changes in cerebral perfusion, such as
cerebral oximetry and so on. The cannulation strategy in acute type
A dissection evolved throughout the study. The majority of
patients early on, and I would say until about 2005 or so, were
cannulated usually through femoral access in the setting of acute
type A dissection. In the setting of elective aneurysm or urgent an-
eurysm repair, if the pathology allowed it, meaning if it wasn’t
very calcified or so on, we would usually cannulate the ascending
aorta and go on bypass that way. We have done axillary perfusion
in a smaller number of patients who presented with an acute type
A dissection, but that is more recently, within the last 3 or 4 years.
I unfortunately don’t have the data separating it out on the basis of
cannulation site as a marker for stroke, but I do understand that
there has been literature prescribing axillary approaches to reduce
the risk of stroke.
Dr Anthony Estrera (Houston, Tex). Himanshu, a nice job. I
think one of the deceptive things when you present your data is
your late reintervention rate, because the reality is howmanyof these
patients you had to reintervene for the arch portion of the graft, be-
cause if you are going to compare this with endovascular therapies,
one of the main limitations with endovascular therapies are all these
endoleaks related to the graft. The reality ismost of your late reinter-
ventions are related to progression of disease distal to your arch
graft, and I would presume that your arch repairs are very durable.
So if you could present some of that data, I think it would be helpful
when you are comparing it as a contemporary series.
DrPatel. If I remember correctly in the analysis, theremay have
been only 1 person who underwent reoperation in this entire series
that we know of who had an anastomotic issue, and that was a pa-
tientwho actually came inwith an infected proximal suture line and
developed a pseudoaneurysm requiring a root and partial ascending
reconstruction. But you are absolutely correct, the majority of late
reoperations are secondary to progression of disease in other aortic
segments, not the treated aortic segment, as you would expect.diovascular Surgery c Volume 141, Number 6 1423
